Gene Expression Profiling Market Overview
The Gene Expression Profiling Market was valued at USD 4.0 billion in 2024 and is projected to reach USD 9.0 billion by 2035, expanding at a CAGR of 7.6% during the 2026–2035 forecast period. The market is benefiting from increasing investments in genomic research, the growing adoption of personalized medicine, rising demand for precision diagnostics, and technological advancements in gene expression analysis.
North America is expected to remain the leading regional market, supported by advanced healthcare infrastructure, strong research capabilities, and significant investments in biotechnology. The region was valued at approximately USD 2.0 billion in 2024 and is projected to reach USD 4.0 billion by 2035. Asia-Pacific is anticipated to record rapid growth as investments in genomics, biotechnology, and healthcare infrastructure continue to increase.
Unlock Exclusive Insights – Request Your Free Sample Report Now!
https://www.wiseguyreports.com/sample-request?id=545219
Key Companies in the Gene Expression Profiling Market
Qiagen
BioRad Laboratories
Roche
SigmaAldrich
Molecular Devices
Merck KGaA
PerkinElmer
Danaher Corporation
Thermo Fisher Scientific
Illumina
Genomatix
Agilent Technologies
The market is being driven by the increasing prevalence of genetic disorders, expanding applications in drug discovery, growing demand for personalized medicine, and greater funding for genomic research. Advances in next-generation sequencing, microarray technologies, quantitative PCR, and RNA sequencing are improving the accuracy, speed, and scalability of gene expression analysis. The integration of artificial intelligence and machine learning is also creating opportunities for more efficient interpretation of complex genomic datasets.
The market is segmented by application, technology, product type, end user, and region. Applications include drug discovery, clinical diagnostics, research and development, and personalized medicine. Technologies include microarray, next-generation sequencing, quantitative PCR, and RNA sequencing. Product types include consumables, instruments, and software, while major end users include pharmaceutical companies, academic and research institutes, and clinical laboratories.
Recent Developments and Market Trends:
Qiagen announced a strategic partnership with Roche Diagnostics in March 2025 to develop integrated gene expression profiling workflows for oncology applications.
Illumina announced the launch of a gene expression profiling product within its sequencing portfolio in May 2025 to support high-throughput transcriptome analysis.
Merck KGaA’s MilliporeSigma announced a collaboration with PerkinElmer in July 2025 to expand multiplexed gene expression profiling for high-throughput drug discovery.
The increasing use of AI and machine learning in genomic data analysis is creating new opportunities for automated and more precise interpretation.
The adoption of cloud-based genomic platforms is improving data sharing and collaboration among researchers and healthcare organizations.
Reasons to Buy the Report:
Understand the current size, growth trajectory, and forecast outlook of the global Gene Expression Profiling Market.
Evaluate key technologies including microarray, NGS, quantitative PCR, and RNA sequencing.
Analyze major applications such as drug discovery, clinical diagnostics, research, and personalized medicine.
Assess regional growth opportunities across North America, Europe, Asia-Pacific, South America, and the Middle East and Africa.
Identify leading companies and understand the competitive landscape of the market.
Examine the impact of genomics innovation, AI, personalized medicine, and biomarker discovery on future market growth.
Future Outlook:
The Gene Expression Profiling Market is expected to maintain strong growth through 2035 as genomic research, precision medicine, and molecular diagnostics continue to expand. Increasing demand for targeted therapies and biomarker discovery, combined with advances in sequencing and data analytics, is likely to broaden the use of gene expression profiling across pharmaceutical research, clinical diagnostics, and personalized healthcare. The integration of AI-driven analytics and automated workflows is also expected to enhance market opportunities over the coming years.
➤➤Explore Our Latest Related Reports:
